News & Events

Feb 10-13, 2026
Dubai, VAE

Meet opTricon GmbH at the WHX Labs in Dubai, VAE from February 10th to 13th, 2026!

Hall 4, Booth E15A

https://www.worldhealthexpo.com/events/labs/dubai/en/home.html

Berlin, Germany – January 13, 2025

Biosynex Technologies GmbH, a leading technology company specializing in the development, production, and maintenance of optical readers for lateral-flow- and fluorescence-based rapid tests, announces a significant change in ownership and a return to its original name, opTricon GmbH. The Berlin-based company has been acquired by a private German investor from Biosynex SA, France (ALBIO.PA). This strategic transaction signals a new chapter for the organization, while reaffirming its commitment to quality, innovation, and collaboration. The company will now operate under its original name, opTricon GmbH, reflecting its roots and long-standing reputation in the diagnostics industry. The entire management team and staff remain in place, ensuring a seamless continuation of the operations of the company in full capacity. Since its founding in 2005, opTricon GmbH has been a global leader in optical reader technology. Over the past decade, the company has supplied more than 40,000 readers to over 300 customers as an OEM manufacturer. These readers, developed and produced in Berlin, Germany, are IVD and FDA approved, adhering to the highest international regulatory standards. The company's products support approximately 300 test applications across diverse industries, including human in vitro diagnostics, veterinary medicine, food safety, pharmaceuticals, homeland security and personal well-being. As part of this transition, opTricon GmbH will maintain its trusted and long-standing partnership with Biosynex SA and its affiliated company, Chembio Diagnostics, Inc. These partnerships will ensure continued collaboration on innovative diagnostic solutions, offering reliable, high-quality products to customers worldwide. The renaming of the company to opTricon GmbH represents not only a return to its origins but also a reaffirmation of its mission to deliver world-class technology and services. The company is well-positioned to expand its market presence while maintaining the high standards that customers and partners have come to expect. 

For inquiries, please contact:  

Lutz Melchior
Managing Director
opTricon GmbH
+49 30 6392 2035
info[at]optricon.de

About opTricon GmbH 

opTricon GmbH (formerly Biosynex Technologies GmbH) is a Berlin-based technology company specializing in the development, manufacturing, and servicing of optical readers for lateral-flow- and fluorescence-based rapid tests. With more than 40,000 readers deployed globally, opTricon supports diverse applications in human in-vitro diagnostics, veterinary medicine, food safety and security. Known for its precision engineering and highest quality, opTricon GmbH continues to be a trusted OEM partner in the global diagnostics market. 

About Biosynex SA and Chembio Diagnostics, Inc, 

Biosynex SA and its affiliated company, Chembio Diagnostics, Inc., are leaders in the global diagnostics field, known for their innovative solutions and commitment to quality. Together with opTricon GmbH, they remain dedicated to fostering strong partnerships and advancing reliable, high-performing diagnostic technologies.

September 2020
Berlin

A consortium of twelve partners successfully applied for a concept phase with the joint project “PolyChrome Berlin - Photonic Integration Platform for Sensory and Analytical Applications in a Wide Wavelength Range - Berlin” as part of the tender “RUBIN - Regional entrepreneurial alliances for innovation” of the Federal Ministry of Education and Research, Germany.

PolyChrome Berlin (polychrome-berlin.de)

http://www.polyphotonics-berlin.de/polychrome-berlin/
https://www.innovation-strukturwandel.de/de/2726.php

June 2020
Berlin

Chembio Diagnostics GmbH ("CDG", former opTricon GmbH) launches their new website.